The corticosteroid laminitis story: 2. Science of if, when and how

Equine Veterinary Journal

Volumn 39, Issue 1, 2007, Pages 7-11

  Bailey, S R ^a   Elliott, J ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ANIMAL; ANIMAL DISEASE; ANIMAL LAMENESS; CHEMICALLY INDUCED DISORDER; EVIDENCE BASED MEDICINE; FOOT DISEASE; HOOF AND CLAW; HORSE; HORSE DISEASE; PATHOLOGY; REVIEW; RISK FACTOR;

ANIMALS; EVIDENCE-BASED MEDICINE; FOOT DISEASES; GLUCOCORTICOIDS; HOOF AND CLAW; HORSE DISEASES; HORSES; LAMENESS, ANIMAL; RISK FACTORS;

EID: 33845972623     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516407X166035     Document Type: Review

References (84)

1. Bailey, S.R. (1998) A Study of the Vascular Effects and Factors Regulating the Concentration of 5-hydroxytryptamine in the Equine Digital Circulation, PhD Thesis, University of London.
2. Bailey, S.R. and Elliott, J. (1998) Plasma 5-hydroxytryptamine constricts equine digital blood vessels in vitro: implications for the pathogenesis of acute laminitis. Equine vet. J. 30, 124-130.
3. Bailey, S.R., Wheeler-Jones, C. and Elliott, J. (2003) Uptake of 5-hydroxytryptamine by equine digital vein endothelial cells: inhibition by amines found in the equine caecum. Equine vet. J. 35, 164-169.
4. Bailey, S.R., Marr, C.M. and Elliott, J. (2004a) Review: Current research and theories on the pathogenesis of acute laminitis in the horse. Vet. J. 167, 129-142.
5. Bailey, S.R., Menzies-Gow, N., Marr, C.M. and Elliott, J. (2004b) The effects of vasoactive amines found in the equine hindgut on digital blood flow in the normal horse. Equine vet. J. 36, 267-272.
6. Beer, H.D., Fassler, R. and Werner, S. (2000) Glucocorticoid-related gene expression during cutaneous wound repair. Vitam. Horm. 59, 217-239.
7. Bertone, J.J. and Horspool, L.J. (2004). Drugs and dosages for use in equines. In: Equine Clinical Pharmacology, 1st edn, Eds: J.J. Bertone and L.J. Horspool, W.B. Saunders, Philadelphia. p 380.
8. Black, S.J., Lunn, D.P., Yin, C., Hwang, M., Lenz, S.D. and Belknap, J.K. (2006) Leukocyte emigration in the early stages of laminitis. Vet. Immunol. Immunopathol. 109, 161-166.
9. Carrier, G.O. and White, R.E. (1985) Enhancement of alpha-1 and alpha-2 adrenergic agonist-induced vasoconstriction by removal of endothelium in rat aorta. J. Pharmacol. expt. Ther. 232, 682-687.
10. Coffman, J.R. and Colles, C.M. (1983). Insulin tolerance in laminitic ponies. Can. J. comp. Med. 47, 347-351.
11. Cornelisse, C.J. and Robinson, N.E. (2004). Glucocorticoid therapy and laminitis: fact or fiction? Equine vet. Educ. 16, 90-93.
12. Cornelisse, C.J., Robinson, N.E., Berney, C.A., Eberhart, S., Hauptman, J.E. and Derksen, F.J. (2006) Thermographic study of in vivo modulation of vascular responses to phenylephrine and endothelin-1 by dexamethasone in the horse. Equine vet. J. 38, 119-126.
13. Cripps, P.J. and Eustace, R.A. (1999) Factors involved in the prognosis of equine laminitis in the UK. Equine vet. J. 31, 433-442.
14. Daradka, M. and Pollitt, C.C. (2004) Epidermal cell proliferation in the equine hoof wall. Equine vet. J. 36, 236-241.
15. Dorscheid, D.R., Wojcik, K.R., Sun, S., Marroquin, B. and White, S.R. (2001) Apoptosis of airway epithelial cells induced by corticosteroids. Am. J. Respir. crit. care Med. 164, 1939-1947.
16. Dutton, H. (2007) The corticosteroids laminitis story: 1. Duty of care. Equine vet. J. 39, 5-6.
17. Eades, S.C., Stokes, A.M. and Moore, R.M. (2006) Effects of an endothelin receptor antagonist and nitroglycerin on digital vascular function in horses during the prodromal stages of carbohydrate overload-induced laminitis. Am. J. vet. Res. 67, 1204-1211.
18. el-Shabrawi, Y., Eckhart, M., Berghold, A., Faulborn, J., Auboeck, L, Mangge, H. and Ardjomand, N. (2000) Synthesis of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone. Eye 14, 375-383.
19. Eustace, R.A. and Redden, R.R. (1990) Iatrogenic laminitis. Vet. Rec. 126, 586.
20. Eyre, P., Elmes P.J. and Strickland, S. (1979) Corticosteroid-potentiated vascular responses of the equine digit: a possible pharmacologic basis for laminitis. Am. J. vet. Res. 40, 135-138.
21. Eyre, P. and Elmes, P.J. (1980) Corticosteroid-induced laminitis? Further investigations on the isolated, perfused hoof. Vet. Res. Comm. 4, 139-143.
22. Faleiros, R.R., Stokes, A.M., Eades, S.C., Kim, D.Y., Paulsen, D.B. and Moore, R.M. (2004) Assessment of apoptosis in epidermal lamellar cells in clinically normal horses and those with laminitis. Am. J. vet. Res. 65, 578-585.
23. Fontaine, G.L., Belknap, J.K., Allen, D., Moore, J.N. and Kroll, D.L. (2001) Expression of interleukin-1β in the digital laminae of horses in the prodromal stage of experimentally induced laminitis. Am. J. vet. Res. 62, 714-720.
24. Frederick, D.M. and Kehl, M. (2000) Case report: Back from the brink. Equus 272, 34-41.
25. French, K.R. and Pollitt, C.C. (2004) Equine laminitis: glucose deprivation and MMP activation induce dermo-epidermal separation in vitro. Equine vet. J. 36, 261-266.
26. French, K., Pollitt, C.C. and Pass, M.A. (2000) Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses. J. vet. Pharmacol. Therap. 23, 287-292.
27. Gaffin, S.L., Gathiram, P., Wells, M.T. and Brock-Utne, J.G. (1986) Effect of corticosteroid prophylaxis on lipopolysaccharide levels associated with intestinal ischemia in cats. Crit. Care Med. 14, 889-891.
28. Gillespie J.S. (1973) Uptake of noradrenaline by smooth muscle. Br. med. Bull. 29, 136-141.
29. Gillis, C.N. and Pitt B.R. (1982) The fate of circulating amines within the pulmonary circulation. Ann. Rev. Physiol. 44, 269-281.
30. Gras, M.P., Verrechia, F. and Uitto, J. (2001) Downregulation of human type VII collagen (COL7A1) promoter activity by dexamethasone. Identification of a glucocorticoid binding region. Expt. Dermatol. 10, 28-34.
31. Grosenbaugh, D.A., Hood, D.M., Amoss, M.S. and Williams, J.D. (1991) Characterisation and distribution of epidermal growth factor receptors in equine hoof wall laminar tissue: comparison of normal horses and horses affected with chronic laminitis. Equine vet. J. 23, 201-206.
32. Harkins, J.D., Carney, J.M. and Tobin, T. (1993) Clinical use and characteristics of the corticosteroids. Vet. Clin. N. Am.: Equine Pract. 9, 543-561.
33. Hendry, K.A.K., MacCallum, A.J., Knight, C.H. and Wilde, C.J. (1999) Effect of endocrine and paracrine factors on protein synthesis and cell proliferation on bovine hoof tissue culture. J. Dairy Res. 66, 23-33.
34. Hood, D.M., Stephens, K.A. and Amoss, M.S. (1982a) The effect of exogenous steroid on the carbohydrate overload model of equine laminitis: a preliminary report. Am. Ass. Pract. Newslett. 2, 149-151.
35. Hood, D.M., Stephens, K.A. and Amoss, M.S. (1982b) The use of alpha and beta-adrenergic blockade as a preventative in the carbohydrate overload model of laminitis: a preliminary report. Am. Ass. Pract. Newslett. 2, 142-145.
36. Hood, D.M., Grosenbaugh, D.A., Mostafa, M.B., Morgan, S.J. and Thomas, B.C. (1993) The role of vascular mechanisms in the development of acute equine laminitis. J. vet. int. Med. 7, 228-233.
37. Hunt, R.J. (1991) The pathophysiology of acute laminitis. Compend. cont. Vet. Educ. 13, 401-407.
38. Iversen, L.L. (1973) Catecholamine uptake processes. Br. med. Bull. 29, 528-530.
39. Iversen, L.L. and Salt, P.J. (1970) Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. Br. med. Bull. 26, 528-530.
40. Johnson, P.J. (2002) The equine metabolic syndrome peripheral Cushing's syndrome. Vet. Clin. N. Am.: Equine Pract. 18, 271-293.
41. Johnson, P.J., Slight, S.H., Ganjam, V.K. and Kreeger, J.M. (2002) Glucocorticoids and laminitis in the horse. Vet. Clin. Equine 18, 219-236.
42. Johnson, P.J., Ganjam, V.K., Slight, S.H., Kreeger, J.M. and Messer, N.T. (2004a) Tissue-specific dysregulation of cortisol metabolism in equine laminitis. Equine vet. J. 36, 41-45.
43. Johnson, P.J., Messer, N.T. and Ganjam, V.K. (2004b) Cushing's syndromes, insulin resistance and endocrinopathic laminitis. Equine vet. J. 36, 194-198.
44. Johnson, P.J, Tyagi, S.C, Katwa, L.C, Ganjam, V.K, Moore, L.A, Kreeger, J.M. and Messer, N.T. (1998) Activation of extracellular matrix metalloproteases in equine laminitis. Vet. Rec. 142, 392-396.
45. Keh, D., Goodman, S. and Sprung, C.L. (2004) Corticosteroid therapy in patients with severe sepsis and septic shock. Semin. Respir. Crit. Care Med. 25, 713-719.
46. Kiziltas, S., Imeryuz, N., Gurcan, T., Siva, A., Saip, S., Dumankar, A., Kalayci, C. and Ulusoy, N.B. (1998) Corticosteroid therapy augments gastro-duodenal permeability to sucrose. Am. J. Gastroenterol. 93, 2420-2425.
47. Kreuger, A.S., Kinden, D.A., Garner, H.E. and Sprouse, R.F. (1986) Ultrastructural study of the equine caecum during onset of laminitis. Am. J. vet. Res. 47, 1804-1812.
48. Kyaw-Tanner, M. and Pollitt, C.C. (2004) Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. Equine vet. J. 36, 221-225.
49. LaRosa, S.P. (2005) Use of corticosteroids in the sepsis syndrome: what do we know now? Cleveland Clinic J. Med. 72, 1121-1127.
50. Lawrence, R., Fessler, J.F., Gall, C.M. and Milne, F.J. (1985) Clinical Forum: Questions and answers. Steroid-induced laminitis. Equine Pract. 7, 31-32.
51. Lee, S.W., Tsou, A.P., Chan, H., Thomas, J., Petrie, K., Eugui, E.M. and Allison, A.C. (1988) Glucocorticoids selectively inhibit the transcription of the interleukin-1 beta gene and decrease the stability of interleukin-1 beta mRNA. Proc. Natl. Acad. Sci. USA. 85, 1204-1208.
52. Lepage, O.M., Laverty, S., Marcoux, M. and Dumas, G. (1993). Serum osteocaclin concentration in horses treated with triamcinolone acetonide. Am. J. vet. Res. 54, 1209-1212.
53. Liu, L., Wang, Y.X., Zhou, J., Long, F., Sun, H.W., Liu, Y., Chen, Y.Z. and Jiang, C.L. (2005) Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation. Inflamm. Res. 54, 37-41.
54. Lose, M.P. (1980) Drug-induced laminitis in a colt. Modern vet. Pract. 61, 608-610.
55. Love, S. (1993) Equine Cushing's disease. Br. vet. J. 149, 139-153.
56. McCluskey, M.J. and Kavenagh, P.B. (2004) Clinical use of triamcinolone acetonide in the horse (205 cases) and the incidence of glucocorticoid-induced laminitis associated with its use. Equine vet. Educ. 16, 86-89.
57. McConnico, R.S., Holm, A.S., Eades, S.C. and Moore, R.M. (2002) The effect of Black Walnut extract on equine colonic histopathology and in vitro ion transport. In: Proceedings of the Seventh Colic Research Symposium, Equine Veterinary Journal, Newmarket, Ltd. pp 129-130.
58. McCoy, B.J., Diegelmann, R.F. and Cohen, I.K. (1980) In vitro inhibition of cell growth, collagen biosynthesis and prolylhydroxylane activity by triamcinolone acetonide. Proc. Soc. expt. biol. Med. 153, 216-222.
59. McCue, P.M. (2002) Equine Cushing's disease. Vet. Clin. N. Am.: Equine Pract. 18, 533-543.
60. McGowan, C.M. and Neiger, R. (2003) Efficacy of trilostane for the treatment of equine Cushing's syndrome. Equine vet. J. 35, 414-418.
61. McIlwraith, C.W. (1987) Diseases of joints, tendons, ligaments and related structures. In: Adams' Lameness in Horses, Ed: T.S. Stashak, Lea and Febiger, Philadelphia. pp 339-485.
62. Mobasheri, A., Critchlow, K., Clegg, P.D., Carter, S.D. and Canessa, C.M. (2004) Chronic equine laminitis is characterised by loss of GLUT1, GLUT4 and ENaC positive laminar keratinocytes. Equine vet. J. 36, 248-254.
63. Moore, J.N. and Allen, D. (1996) The pathophysiology of acute laminitis. Vet. Med. 34, 936-939.
64. Paiva, M.Q., Caramona, M. and Osswald, W. (1984) Intra- and extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog. Naunyn-Schmiedeberg Arch. Pharmacol. 325, 62-68.
65. Pass, M.A., Pollitt, S. and Pollitt, C.C. (1998) Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis? Equine vet. J., Suppl. 26, 133-138.
66. Pollitt, C.C. and Daradka, M. (1998) Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining. Equine vet. J., Suppl. 26, 139-144.
67. Rice, T.W. and Bernard, G.R. (2005) Therapeutic intervention and targets for sepsis. Ann. Rev. Med. 56, 225-248.
68. Richardson, D.W. and Dodge, G.R. (2003) Dose-dependent effects of corticosteroids on expression of matrix-related genes in normal and cytokine-treated articular chondrocytes. Inflamm. Res. 52, 39-49.
69. Roberts, D. (1965) Treatment of laminitis by intra-arterial infusion of adrenocorticoid steroids. Vet. Med. small anim. Clin. 60, 1109-1113.
70. Ryu, S., Kim, B., Lee, C., Yoon, J. and Lee, Y.L. (2004) Glucocorticoid-induced laminitis with hepatopathy in a Thoroughbred filly. J. vet. Sci. 5, 271-274.
71. Sakaue, M. and Hoffman, B.B. (1991) Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J. clin. Invest. 88, 385-389.
72. Sakoda, H., Ogihara, T., Anai, M., Funaki, M., Inukai, K., Katagiri, H., Fukushima, Y., Onishi, Y., Ono, H., Fujishiro, M., Kikuchi, M., Oka, Y. and Asano, T. (2000) Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes 49, 1700-1708.
73. Sheffield, L.G. (1998) Hormonal regulation of epidermal growth factor receptor content and signaling in bovine mammary tissue. Endocrinol. 139, 4568-4575.
74. Shupnik, M.A., Chrousos, G.P. and Siragy, H.M. (1998) Glucocorticoids and mineralocorticoids. In: Human Pharmacology: Molecular to Clinical. Eds: T.M. Brody, J. Larner and K.P. Minneman, Mosby Inc., St. Louis. pp 485-497.
75. Simon, F., Laczay, P., Mora, Z. and Lehel, J. (1990) Target animal safety test of a dexamethasone-prednisolone combination in horses. Dtsch Tierarztl Wochenschr. 97, 339-340, 342.
76. Slater, M.R., Hood, D.M. and Carter, G.K. (1995) Descriptive epidemiological study of equine laminitis. Equine vet. J. 27, 364-367.
77. Treiber, K.H., Kronfeld, D.S. and Geor, R.J. (2006) Insulin resistance in equids: possible role in laminitis. J. Nutr. 136 (Suppl. 7), 2094S-2098S.
78. Tse, R., Marroquin, B.A., Dorscheid, D.R. and White, S.R. (2003) Beta-adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L393-404.
79. Tumas, D.B., Hines, M.T., Perryman, L.E., Davis, W.C. and McGuire, T.C. (1994) Corticosteroid immunosuppression and monoclonal antibody-mediated CD5+ T lymphocyte depletion in normal and infectious anaemia virus-carrier horses. J. Gen. Virol. 75, 959-968.
80. van der Kolk, J.H., Wensing, T., Kalsbeek, H.C. and Breukink, H.J. (1995) Laboratory diagnosis of equine pituitary pars intermedia adenoma. Domest. Anim. Endocrinol. 12, 35-39.
81. Waguespack, R.W., Kemppainen, R.J., Cochran, A., Lin, H.C. and Belknap, J.K. (2004a) Increased expression of MAIL, a cytokine-associated nuclear protein, in the prodromal stage of black walnut-induced laminitis. Equine vet. J. 36, 285-291.
82. Waguespack, R.W., Cochran, A. and Belknap, J.K. (2004b) Expression of the cyclooxygenase isoforms in the prodromal stage of black walnut-induced laminitis in horses. Am. J. vet. Res. 65, 1724-1729.
83. Wattle, O. and Pollitt, C.C. (2004) Lamellar metabolism. Clin. Tech. equine Pract. 3, 22-33.
84. Weiss, D.J., Evanson, O.A., Macleay, J. and Brown, D.R. (1998) Transient alteration in intestinal permeability to technetium Tc99m diethylenetriamino- pentaacetate during the prodromal phase of alimentary laminitis in ponies. Am. J. vet. Res. 59, 1431-1434.